Dentistry

Being overweight linked to higher risk of gum disease

Impacting approximately one-third of the U.S. population, obesity is a significant health concern for Americans. It's a risk factor for developing type 2 diabetes, heart disease, and certain forms of cancer, and now, according ...

Parkinson's & Movement disorders

Study identifies a potential cause of Parkinson's disease

Deciphering what causes the brain cell degeneration of Parkinson's disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor ...

Immunology

Dermatitis could be suppressed as it develops

Excessive immune reactions against the body's own skin cells can lead to painful and even chronic dermatitis. An international team of researchers at the MedUni Vienna, the MedUni Graz and the Salk Institute in California, ...

Surgery

New procedure for bone tissue replacement

A Simon Fraser University technology MBA graduate has developed a new procedure for bone tissue engineering and plans to use his newfound business acumen to take the research to the next level.

Medications

Aubagio approved for multiple sclerosis

(HealthDay)—Aubagio (teriflunomide) has been approved by the U.S. Food and Drug Administration to treat adults with relapsing forms of multiple sclerosis (MS).

Other

New technology to transform blood processing

A pioneering surgical blood salvage technology developed at the University of Strathclyde, Glasgow, is set to transform the way major surgery is carried out by reducing blood loss in patients.

Arthritis & Rheumatism

Study shows efficacy of new rheumatoid arthritis drug

(Medical Xpress) -- A new study involving researchers from Karolinska Institutet demonstrates the efficacy of Tofacitinib, a new drug for rheumatoid arthritis. According to the study, which is published in The New England ...

page 7 from 9